Search company, investor...
hemotune company logo


Founded Year



Series B | Alive

Total Raised


Last Raised

$7.58M | 9 mos ago

About hemotune

hemotune develops a medical device for the purification of blood in acute care, focusing on crafting an efficient therapy for patients with sepsis.

Headquarters Location

Wagistrasse 27

Schlieren, 8952,


+41 77 512 36 98

hemotune's Product Videos

Compete with hemotune?

Ensure that your company and products are accurately represented on our platform.

hemotune's Products & Differentiators


    Reusable active medical device similar to a dialysis machine for magnetic blood purification. It pumps blood outside of the body and adds and removes magnetic beads to/from the blood. The HemoDevice can be used for different indications.

Expert Collections containing hemotune

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

hemotune is included in 2 Expert Collections, including Medical Devices.


Medical Devices

8,605 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

hemotune Patents

hemotune has filed 1 patent.

The 3 most popular patent topics include:

  • Causes of death
  • Human female endocrine system
  • Intensive care medicine
patents chart

Application Date

Grant Date


Related Topics



Intensive care medicine, Human female endocrine system, Rare diseases, Causes of death, Syndromes


Application Date


Grant Date


Related Topics

Intensive care medicine, Human female endocrine system, Rare diseases, Causes of death, Syndromes



Latest hemotune News

Swiss startups get global exposure

Nov 15, 2022

Five high-tech startup competitions collected awards from various startup competitions worldwide including the US, the Nordics, Singapore. Fintech startup scored a spot in Global Fintech Hackcelerator while Hemotune’s solution got recognition from Frost & Sullivan, one of the most recognized market research companies.

hemotune Frequently Asked Questions (FAQ)

  • When was hemotune founded?

    hemotune was founded in 2017.

  • Where is hemotune's headquarters?

    hemotune's headquarters is located at Wagistrasse 27, Schlieren.

  • What is hemotune's latest funding round?

    hemotune's latest funding round is Series B.

  • How much did hemotune raise?

    hemotune raised a total of $14.57M.

  • Who are the investors of hemotune?

    Investors of hemotune include Occident Group, Zurcher Kantonalbank, Hemex, VP Venture Partners, Venturelab and 10 more.

  • Who are hemotune's competitors?

    Competitors of hemotune include ExThera Medical and 3 more.

  • What products does hemotune offer?

    hemotune's products include HemoDevice and 2 more.

  • Who are hemotune's customers?

    Customers of hemotune include University Hospital Bern.

Compare hemotune to Competitors

MediSieve Logo

MediSieve is developing a magnetic blood filter able to remove disease-causing agents from blood to treat blood-borne diseases. Similar to dialysis, blood is circulated through a magnetic blood filter which captures and removes targets based on their magnetic properties.


PATH EX is developing an extracorporeal blood cleansing device designed to selectively remove pathogens, including multi-drug resistant bacteria, and endotoxins from circulating blood.

ExThera Medical Logo
ExThera Medical

ExThera Medical is a privately-held medical device company developing a single-use blood filter capable of capturing and removing a broad range of bacteria, viruses, parasites, toxins, and other harmful substances from whole blood. The company intends to develop therapeutic products to treat patients in the clinic or hospital, as well as devices that purify donated, banked blood prophylactically before transfusion.

BOA Biomedical Logo
BOA Biomedical

BOA Biomedical develops a medical device that rapidly diagnoses and treats infectious diseases, with a special focus on sepsis and antibiotic-resistant pathogens.

CytoSorbents Logo

CytoSorbents (NASDAQ: CTSO) is a New Jersey-based, critical care immunotherapy company specializing in blood purification to control deadly inflammation in critically-ill and cardiac surgery patients.

Cheetah Medical Logo
Cheetah Medical

Cheetah Medical is a provider in non-invasive Cardiac Output and Hemodynamic monitoring. The company is focused on development and commercialization of an accurate non-invasive solution for the monitoring of critically ill patients. Cheetah Medical's NICOM Noninvasive Hemodynamic Monitoring System is based on the company's BIOREACTANCE technology. On September 10, 2019, Cheetah Medical was acquired by Baxter at a valuation of between $190M and $230M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.